SCHEMBL9944758

SCHEMBL9944758

CCNc1cc(F)c(C(=O)OCC)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
LMNA P02545 4/20 0.56
POLB P06746 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
GALR2 O43603 1/20 0.56
MITF O75030 1/20 0.56
HSP90AA1 P07900 1/20 0.56
HPGD P15428 1/20 0.56
XBP1 P17861 1/20 0.56
CCR6 P51684 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
MAPT P10636 8/20 0.50
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.50
PKM P14618 1/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
KMT2A Q03164 1/20 0.48
PTGER4 P35408 1/20 0.47
HCAR3 P49019 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL670956 0.88 ALDH1A1 (0.57) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL9898390 0.88 ALDH1A1 (0.55) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL1966149 0.86 ALDH1A1 (0.73) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL1967194 0.85 ALDH1A1 (0.49) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL17008983 0.85 ALDH1A1 (0.56) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL17937026 0.84 HCAR3 (0.49) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL8191133 0.84 LMNA (0.53) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL670959 0.84 ALDH1A1 (0.57) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL17930514 0.82 ALDH1A1 (0.56) ALDH1A1LMNAPOLBSMN1; SMN2GALR2
SCHEMBL25352364 0.81 ALDH1A1 (0.53) ALDH1A1LMNAPOLBSMN1; SMN2GALR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885LMNA 1817/4885POLB 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.